Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

2.50
Hdl Handle:
http://hdl.handle.net/10029/621055
Title:
Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.
Authors:
van der Heiden, Marieke; Boots, Annemieke M H; Bonacic Marinovic, Axel A; de Rond, Lia G H; van Maurik, Marjan; Tcherniaeva, Irina; Berbers, Guy A M; Buisman, Anne-Marie
Abstract:
Vaccine responses are often reduced in the elderly, leaving part of the elderly population vulnerable to infectious diseases. Timely vaccination may offer a solution for strengthening memory immunity before reaching old age, which classifies middle-aged persons as a target age group for vaccine interventions. However, knowledge regarding the immunogenicity of primary immunizations in middle-aged adults is lacking. We determined the immunogenicity of a primary meningococcal vaccine towards which no or (very) low pre-vaccination immunity exists in middle-aged adults (NTR4636).
Citation:
Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults. 2017, 8:817 Front Immunol
Journal:
Front Immunol 2017, 8:817
Issue Date:
2017
URI:
http://hdl.handle.net/10029/621055
DOI:
10.3389/fimmu.2017.00817
PubMed ID:
28769927
Type:
Article
Language:
en
ISSN:
1664-3224
Appears in Collections:
Miscellaneous

Full metadata record

DC FieldValue Language
dc.contributor.authorvan der Heiden, Mariekeen
dc.contributor.authorBoots, Annemieke M Hen
dc.contributor.authorBonacic Marinovic, Axel Aen
dc.contributor.authorde Rond, Lia G Hen
dc.contributor.authorvan Maurik, Marjanen
dc.contributor.authorTcherniaeva, Irinaen
dc.contributor.authorBerbers, Guy A Men
dc.contributor.authorBuisman, Anne-Marieen
dc.date.accessioned2018-01-09T12:14:58Z-
dc.date.available2018-01-09T12:14:58Z-
dc.date.issued2017-
dc.identifier.citationNovel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults. 2017, 8:817 Front Immunolen
dc.identifier.issn1664-3224-
dc.identifier.pmid28769927-
dc.identifier.doi10.3389/fimmu.2017.00817-
dc.identifier.urihttp://hdl.handle.net/10029/621055-
dc.description.abstractVaccine responses are often reduced in the elderly, leaving part of the elderly population vulnerable to infectious diseases. Timely vaccination may offer a solution for strengthening memory immunity before reaching old age, which classifies middle-aged persons as a target age group for vaccine interventions. However, knowledge regarding the immunogenicity of primary immunizations in middle-aged adults is lacking. We determined the immunogenicity of a primary meningococcal vaccine towards which no or (very) low pre-vaccination immunity exists in middle-aged adults (NTR4636).en
dc.language.isoenen
dc.rightsArchived with thanks to Frontiers in immunologyen
dc.titleNovel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.en
dc.typeArticleen
dc.identifier.journalFront Immunol 2017, 8:817en

Related articles on PubMed

All Items in WARP are protected by copyright, with all rights reserved, unless otherwise indicated.